{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T19:40:28Z","timestamp":1738266028491,"version":"3.35.0"},"posted":{"date-parts":[[2025]]},"group-title":"SSRN","reference-count":41,"publisher":"Elsevier BV","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.2139\/ssrn.5113688","type":"posted-content","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:57:17Z","timestamp":1738263437000},"source":"Crossref","is-referenced-by-count":0,"title":["Surgical Staging Identifies Occult Metastases in Over 50% of Uterine-Confined Carcinosarcoma"],"prefix":"10.2139","author":[{"given":"William","family":"Vintzileos","sequence":"first","affiliation":[]},{"given":"Hannah","family":"Beer","sequence":"additional","affiliation":[]},{"given":"David  Scott","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Jayanthi","family":"Lea","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"ref1","article-title":"Key statistics for endometrial cancer","year":"2024","journal-title":"Cancer.org"},{"issue":"3","key":"ref2","article-title":"Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database","volume":"12","author":"J W Lee","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"ref3","article-title":"Adjuvant radiotherapy and\/or chemotherapy after surgery for uterine carcinosarcoma","volume":"2013","author":"K Galaal","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ijgc-00009577-200211000-00001","article-title":"Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas","volume":"12","author":"W G Mccluggage","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/PGP.0000000000000346","article-title":"Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics","volume":"36","author":"X Chen","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2008.12.014","article-title":"Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma","volume":"143","author":"K Galaal","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2015.03.041","article-title":"Uterine carcinosarcoma: A review of the literature","volume":"137","author":"L A Cantrell","year":"2015","journal-title":"Gynecol Oncol"},{"key":"ref8","year":"2019","journal-title":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: uterine neoplasms. National Comprehensive Cancer Network"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1245\/s10434-009-0833-6","article-title":"The role of pelvic and\/or paraaortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus","volume":"17","author":"J Y Park","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.2147\/CMAR.S267128","article-title":"A Study of Prognostic Factors of Chinese Patients with Gynecologic Tract Carcinosarcomas Prognosis of Gynecologic Carcinosarcomas","volume":"12","author":"D Ye","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10147-017-1181-3","article-title":"Prognostic factors for diseasefree and overall survival of patients with uterine carcinosarcoma","volume":"23","author":"Y E ?\ufffdk\ufffdr","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10147-015-0859-7","article-title":"Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group","volume":"21","author":"K Harano","year":"2016","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/IGC.0b013e3181dc8292","article-title":"Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes","volume":"20","author":"G Garg","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271526","article-title":"Uterine carcinosarcoma: A 10-year single institution experience","volume":"17","author":"L Terblanche","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"E Von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1)","volume":"45","author":"E A Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1200\/JCO.21.02050","article-title":"Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial","volume":"40","author":"M A Powell","year":"2022","journal-title":"J Clin Oncol"},{"issue":"16","key":"ref18","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1200\/JCO.2009.26.8326","article-title":"Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"28","author":"M A Powell","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2004.11.022","article-title":"Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study","volume":"96","author":"G Sutton","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer","volume":"388","author":"M R Mirza","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/PAS.0000000000001434","article-title":"Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Multi-institution Retrospective Review","volume":"44","author":"T M Jenkins","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"ref22","volume":"19","author":"N P Taylor","year":"2006","journal-title":"DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis [published correction appears in Mod Pathol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/modpathol.3800654","volume":"19","year":"2006","journal-title":"Mod Pathol"},{"issue":"15","key":"ref24","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/1078-0432.CCR-20-0953","article-title":"Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2\/Neu (NCT01367002): Updated Overall Survival Analysis","volume":"26","author":"A N Fader","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2007.09.007","article-title":"An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"108","author":"T A Grushko","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"8","key":"ref26","article-title":"The Expression and Amplification of HER2 Has a Significant Impact on the Prognosis of Endometrial Carcinoma in Korean Patients","volume":"13","author":"W Y Kim","year":"2009","journal-title":"J Clin Med"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2005.08.017","article-title":"Clinical significance of Her-2\/neu overexpression in uterine serous carcinoma","volume":"100","author":"T P D\ufffdaz-Montes","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"15","key":"ref28","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.22.02558","article-title":"Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial","volume":"41","author":"T Nishikawa","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2020.04.012","article-title":"Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study","volume":"133","author":"W J Van Weelden","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2015.08.014","article-title":"Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis","volume":"139","author":"J A Rauh-Hain","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0360-3016(03)01561-X","article-title":"Malignant mixed M\ufffdllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome","volume":"58","author":"M Callister","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"E C Rossi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1525-1438.2006.00762.x","article-title":"Early-stage carcinosarcoma of the uterus: the significance of lymph node count","volume":"17","author":"S M Temkin","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"ref34","article-title":"Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer","volume":"44","author":"A A Garrett","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ygyno.2006.03.055","article-title":"The incidence of symptomatic lowerextremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center","volume":"103","author":"N R Abu-Rustum","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"ref36","first-page":"240","article-title":"Postoperative neuropathies after major pelvic surgery","volume":"100","author":"R J Cardosi","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref37","volume":"60","author":"V Pergialiotis","year":"2024","journal-title":"The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(20000615)88:12<2782::AID-CNCR17>3.0.CO;2-K","article-title":"Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus","volume":"88","author":"S D Yamada","year":"2000","journal-title":"Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0090-8258(89)80041-1","article-title":"Management of malignant, mixed, mesodermal tumors of the uterus","volume":"32","author":"E S Podzaski","year":"1989","journal-title":"Gynecol Oncol"},{"key":"ref40","author":"Giannice","journal-title":"Surgical upstaging versus provisional clinical stage by computed tomography in type II endometrial cancer: A retrospective Study"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s00261-019-02038-8","article-title":"Uterine carcinosarcoma: a primer for radiologists","volume":"44","author":"P Ravishankar","year":"2019","journal-title":"Abdominal Radiology"}],"container-title":[],"original-title":[],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T19:00:34Z","timestamp":1738263634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ssrn.com\/abstract=5113688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"URL":"https:\/\/doi.org\/10.2139\/ssrn.5113688","relation":{},"subject":[],"published":{"date-parts":[[2025]]},"subtype":"preprint"}}